Evidence map›Paper›PMID 38444343›Full record

ArticlePediatrics2024

National Quality Indicators in Pediatric Sickle Cell Anemia.

Ashaunta T Anderson, Wendy J Mack, Sophia S Horiuchi, Susan Paulukonis, Mei Zhou, Angela B Snyder, Jason N Doctor, Michele Kipke, Thomas Coates, Gary Freed

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pediatrics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Ashaunta T AndersonDepartment of Pediatrics, Keck School of Medicine of the University of Southern California, Los Angeles, California.
Wendy J MackDepartment of Pediatrics, Keck School of Medicine of the University of Southern California, Los Angeles, California.
Sophia S HoriuchiTracking California, Richmond, California.
Susan PaulukonisTracking California, Richmond, California.
Mei ZhouGeorgia Health Policy Center, Georgia State University, Atlanta, Georgia.
Angela B SnyderGeorgia Health Policy Center, Georgia State University, Atlanta, Georgia.
Jason N DoctorLeonard D. Schaeffer Center for Health Policy and Economics at the University of Southern California, Los Angeles, California.
Michele KipkeDepartment of Pediatrics, Keck School of Medicine of the University of Southern California, Los Angeles, California.
Thomas CoatesDepartment of Pediatrics, Keck School of Medicine of the University of Southern California, Los Angeles, California.
Gary FreedDepartment of Pediatrics, University of Michigan Medical School, Ann Arbor, Michigan.
University of Southern California · USChildren's Hospital of Los Angeles · USGeorgia State University · USUniversity of Michigan–Ann Arbor · US

Funding

Southern California Clinical and Translational Science InstituteUL1TR001855 · NCATS · UNIVERSITY OF SOUTHERN CALIFORNIA · PI Thomas A Buchanan, Michele D. Kipke · 2016 to 2026
$81.3M
NCATS NIH HHS UL1 TR001855
6 · The paper itself

Abstract

objectiveTo assess nationally endorsed claims-based quality measures in pediatric sickle cell anemia (SCA).

methodsUsing data from the Sickle Cell Data Collection programs in California and Georgia from 2010 to 2019, we evaluated 2 quality measures in individuals with hemoglobin S/S or S/β-zero thalassemia: (1) the proportion of patients aged 3 months to 5 years who were dispensed antibiotic prophylaxis for at least 300 days within each measurement year and (2) the proportion of patients aged 2 to 15 years who received at least 1 transcranial Doppler ultrasound (TCD) within each measurement year. We then evaluated differences by year and tested whether performance on quality measures differed according to demographic and clinical factors.

resultsOnly 22.2% of those in California and 15.5% in Georgia met or exceeded the quality measure for antibiotic prophylaxis, with increased odds associated with rural residence in Georgia (odds ratio 1.61; 95% confidence interval 1.21-2.14) compared with urban residence and a trend toward increased odds associated with a pediatric hematologist prescriber (odds ratio 1.28; 95% confidence interval 0.97, 1.69) compared with a general pediatrician. Approximately one-half of the sample received an annual assessment of stroke risk using TCD (47.4% in California and 52.7% in Georgia), with increased odds each additional year in both states and among younger children.

conclusionsThe rates of receipt of recommended antibiotic prophylaxis and annual TCD were low in this sample of children with SCA. These evidence-based quality measures can be tracked over time to help identify policies and practices that maximize survival in SCA.

Indexed as

Anemia, Sickle CellStrokeChildGeorgiaHumansQuality Indicators, Health CareUltrasonography, Doppler, Transcranial

Identifiers

PMID38444343
PMCPMC10982541
OpenAlexW4392516706

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.